Literature DB >> 12805559

CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation.

Ken-Ichi Imadome1, Masaki Shirakata, Norio Shimizu, Shigeaki Nonoyama, Yuji Yamanashi.   

Abstract

Epstein-Barr virus (EBV), implicated in numerous human diseases, including lymphoid malignancies, persistently infects peripheral B cells and transforms them into lymphoblastoid cell lines. Here we found that EBV equally infected B cells from patients with X-linked hyper IgM syndrome and those from healthy donors; however, it hardly transformed X-linked hyper IgM syndrome B cells, because of the dysfunctional gene of CD40 ligand (CD40L) of the patients. Unlike CD40, CD40L is not usually expressed on B cells. However, we found that EBV infection of normal B cells induced CD40L expression as a critical effector in host cell transformation and survival. Moreover, chronic active EBV infection of peripheral T cells, implicated in T cell malignancies, was associated with ectopic expression of CD40, and, in Jurkat T cells, EBV infection induced CD40 expression. These results suggest that EBV infection induces CD40L/CD40 signaling in host cells, which appears to play an essential role in its persistent infection and malignancies of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805559      PMCID: PMC164674          DOI: 10.1073/pnas.1231363100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  The CD40/CD154 receptor/ligand dyad.

Authors:  U Schönbeck; P Libby
Journal:  Cell Mol Life Sci       Date:  2001-01       Impact factor: 9.261

Review 2.  Epstein-Barr virus: exploiting the immune system.

Authors:  D A Thorley-Lawson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

Review 3.  CD40 and its viral mimic, LMP1: similar means to different ends.

Authors:  Ngan Lam; Bill Sugden
Journal:  Cell Signal       Date:  2003-01       Impact factor: 4.315

4.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

Authors:  J A James; B R Neas; K L Moser; T Hall; G R Bruner; A L Sestak; J B Harley
Journal:  Arthritis Rheum       Date:  2001-05

5.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

6.  Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease.

Authors:  Tetsuya Higuchi; Yuichi Aiba; Takashi Nomura; Junichiro Matsuda; Keiji Mochida; Misao Suzuki; Hitoshi Kikutani; Tasuku Honjo; Kiyoshi Nishioka; Takeshi Tsubata
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

7.  A CD40 Signalosome anchored in lipid rafts leads to constitutive activation of NF-kappaB and autonomous cell growth in B cell lymphomas.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Piao Lo; Nicholas Terry; Pamela S Reid; Richard J Ford
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

8.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

9.  Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR.

Authors:  M Emig; S Saussele; H Wittor; A Weisser; A Reiter; A Willer; U Berger; R Hehlmann; N C Cross; A Hochhaus
Journal:  Leukemia       Date:  1999-11       Impact factor: 11.528

10.  Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Authors:  J Uchida; T Yasui; Y Takaoka-Shichijo; M Muraoka; W Kulwichit; N Raab-Traub; H Kikutani
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

View more
  16 in total

1.  Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.

Authors:  Takako Mori; Takeshi Sairenji
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

2.  Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.

Authors:  Chongmin Huan; Matthew L Kelly; Ryan Steele; Iuliana Shapira; Susan R S Gottesman; Christopher A J Roman
Journal:  Nat Immunol       Date:  2006-08-27       Impact factor: 25.606

3.  Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma.

Authors:  Qin Huang; Qiu-Xia Qu; Fang Xie; Jian-Ming Hu; You-Guo Chen; Xue-Guang Zhang
Journal:  Med Oncol       Date:  2010-05-14       Impact factor: 3.064

4.  Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.

Authors:  David O Willer; Samuel H Speck
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.

Authors:  Georgina J MacArthur; A Douglas Wilson; Martin A Birchall; Andrew J Morgan
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

6.  LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.

Authors:  Shi-Dong Ma; Xuequn Xu; Julie Plowshay; Erik A Ranheim; William J Burlingham; Jeffrey L Jensen; Fotis Asimakopoulos; Weihua Tang; Margaret L Gulley; Ethel Cesarman; Jenny E Gumperz; Shannon C Kenney
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

7.  Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Authors:  Pandelakis A Koni; Anna Bolduc; Mayuko Takezaki; Yutetsu Ametani; Lei Huang; Jeffrey R Lee; Stephen L Nutt; Masahito Kamanaka; Richard A Flavell; Andrew L Mellor; Takeshi Tsubata; Michiko Shimoda
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

8.  Assessment of the effect of TLR7/8, TLR9 agonists and CD40 ligand on the transformation efficiency of Epstein-Barr virus in human B lymphocytes by limiting dilution assay.

Authors:  Vahid Younesi; Forough Golsaz Shirazi; Ali Memarian; Amir Amanzadeh; Mahmood Jeddi-Tehrani; Fazel Shokri
Journal:  Cytotechnology       Date:  2013-02-13       Impact factor: 2.058

9.  EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.

Authors:  Kathy H Y Shair; Katherine M Bendt; Rachel H Edwards; Elisabeth C Bedford; Judith N Nielsen; Nancy Raab-Traub
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

10.  Early events associated with infection of Epstein-Barr virus infection of primary B-cells.

Authors:  Sabyasachi Halder; Masanao Murakami; Subhash C Verma; Pankaj Kumar; Fuming Yi; Erle S Robertson
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.